Skip to main content

 Related scientific articles (all)

First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours.

Authors : Schöffski P, Awada A, de la Bigne AM, Felloussi Z, Burbridge M, Cantero F, Colombo R, Maruzzelli S, Ammattatelli K, de Jonge M, Aftimos P, Dumez H, Sleijfer S
Year : 2022
Journal : Eur J Cancer
Volume : 169
Pages : 135-145

Buschke-Löwenstein tumor in a human immunodeficiency virus-positive patient: a case report and short literature review.

Authors : Ledouble V, Sclafani F, Hendlisz A, Gomez Galdon M, Liberale G
Year : 2021
Journal : Acta Gastroenterol Belg
Volume : 84
Pages : 343-345

Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis.

Authors : Caparica R, Bruzzone M, Agostinetto E, de Angelis C, Fêde Â, Ceppi M, de Azambuja E
Year : 2021
Journal : ESMO Open
Volume : 6
Pages : 100066

Integrated molecular and immune phenotype of HER2-positive breast cancer and response to neoadjuvant therapy: a NeoALTTO exploratory analysis.

Authors : Pizzamiglio S, Ciniselli CM, Triulzi T, Gargiuli C, De Cecco L, de Azambuja E, Fumagalli D, Sotiriou C, Harbeck N, Izquierdo M, Nuciforo P, Huober J, Cappelletti V, Cinieri S, Piccart-Gebhart M, Daidone MG, Pruneri G, Colombo MP, Tagliabue E, Verderio P, Di Cosimo S
Year : 2021
Journal : Clin Cancer Res

Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer.

Authors : Harada G, Neffa MFBV, Bonadio RC, Mendoza EZ, Caparica R, Lauricella LL, Takagaki TY, Roitberg FSR, Terra RM, Castro G Jr
Year : 2021
Journal : J Bras Pneumol
Volume : 47
Pages : e20200378

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.

Authors : Aftimos P, Oliveira M, Irrthum A, Fumagalli D, Sotiriou C, Gal-Yam EN, Robson ME, Ndozeng J, Di Leo A, Ciruelos EM, de Azambuja E, Viale G, Scheepers ED, Curigliano G, Bliss JM, Reis-Filho JS, Colleoni M, Balic M, Cardoso F, Albanell J, Duhem C, Marreaud S, Romagnoli D, Rojas B, Gombos A, Wildiers H, Guerrero-Zotano A, Hall P, Bonetti A, Larsson KF, Degiorgis M, Khodaverdi S, Greil R, Sverrisdóttir Á, Paoli M, Seyll E, Loibl S, Linderholm B, Zoppoli G, Davidson NE, Johannsson OT, Bedard PL, Loi S, Knox S, Cameron DA, Harbeck N, Montoya ML, Brandão M, Vingiani A, Caballero C, Hilbers FS, Yates LR, Benelli M, Venet D, Piccart MJ
Year : 2021
Journal : Cancer Discov
Volume : 11
Pages : 2796-2811

Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.

Authors : Kehrloesser S, Oberst S, Westerhuis W, Wendler A, Wind A, Blaauwgeers H, Burrion JB, Nagy P, Saeter G, Gustafsson E, De Paoli P, Lovey J, Lombardo C, Philip T, de Valeriola D, Docter M, Boomsma F, Saghatchian M, Svoboda M, Philip I, Monetti F, Hummel H, McVie G, Otter R, Van Harten W
Year : 2021
Journal : Mol Oncol
Volume : 15
Pages : 1277-1288

Immunotherapy for early breast cancer: too soon, too superficial, or just right?

Authors : Franzoi MA, Romano E, Piccart-Gebhart M
Year : 2021
Journal : Ann Oncol
Volume : 32
Pages : 323-336

Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-positive Breast Cancer.

Authors : Tolaney SM, Sahebjam S, Rhun EL, Bachelot T, Kabos P, Awada A, Yardley D, Chan A, Conte P, Diéras V, Lin NU, Bear M, Chapman SC, Yang Z, Chen Y, Anders CK
Year : 2021
Journal : Clin Cancer Res
Volume : 27
Pages : 1582

VISTA: A Promising Target for Cancer Immunotherapy?

Authors : Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M
Year : 2021
Journal : Immunotargets Ther
Volume : 10
Pages : 185-200

Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.

Authors : Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Year : 2021
Journal : Mol Cancer Res
Volume : 19
Pages : 1221-1233

Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.

Authors : Meert AP, Wittnebel S, Holbrechts S, Toffart AC, Lafitte JJ, Piagnerelli M, Lemaitre F, Peyrony O, Calvel L, Lemaitre J, Canet E, Demoule A, Darmon M, Sculier JP, Voigt L, Lemiale V, Pène F, Schnell D, Lengline E, Berghmans T, Fiévet L, Jungels C, Wang X, Bold I, Pistone A, Salaroli A, Grigoriu B, Benoit D
Year : 2021
Journal : Intensive Care Med
Volume : 47
Pages : 1063-1077

State of the art and future directions in the systemic treatment of neuroendocrine neoplasms.

Authors : Jungels C, Deleporte A
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 378-385

Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade.

Authors : Belcaid L, Garaud S, Kerger J, Spyridon S, Aspeslagh S
Year : 2021
Journal : Acta Clin Belg
Volume : 76
Pages : 144-148

The NHance<sup>®</sup> Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

Authors : Aftimos P, Rolfo C, Rottey S, Barthélémy P, Borg C, Park K, Oh DY, Kim SW, De Jonge N, Hanssens V, Zwanenpoel K, Molthoff C, Vugts D, Dreier T, Verheesen P, van Dongen GAMS, Jacobs J, Van Rompaey L, Hultberg A, Michieli P, Pauwels P, Fung S, Thibault A, de Haard H, Leupin N, Awada A
Year : 2021
Journal : Biomedicines
Volume : 9

Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far?

Authors : Demetter P, Maréchal R, Puleo F, Delhaye M, Debroux S, Charara F, Gomez Galdon M, Van Laethem JL, Verset L
Year : 2021
Journal : Front Oncol
Volume : 11
Pages : 630086

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Authors : Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G
Year : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pages : 125

Age of Less than Forty Years Seems Not Be an Independent Factor for Poor Prognosis in Patients Undergoing Surgery for CRC.

Authors : Wagner A, Jacob N, Moreau M, Bouazza F, Bohlok A, Deleporte A, Sclafani F, Hendlisz A, Donckier V, Liberale G
Year : 2021
Journal : Journal of cancer research and therapeutic oncology
Volume : 9(2)
Pages : 9-15

Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?

Authors : Hendlisz A, Sclafani F
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 351-352

Tolerability and toxicity of trastuzumab or trastuzumab?+?lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).

Authors : Pondé N, Agbor-Tarh D, Dal Lago L, Korde LA, Hilbers F, Jackisch C, Werner O, Gelber Rd, Jatoi A, Dueck AC, Moreno-Aspitia A, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Year : 2021
Journal : Breast Cancer Res Treat
Volume : 185
Pages : 107-116